Hematological findings and complications of COVID‐19
E Terpos, I Ntanasis‐Stathopoulos… - American journal of …, 2020 - Wiley Online Library
COVID‐19 is a systemic infection with a significant impact on the hematopoietic system and
hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with …
hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with …
Cardiovascular complications in COVID-19
Background The coronavirus disease of 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and …
respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and …
[HTML][HTML] COVID-19 cytokine storm: the interplay between inflammation and coagulation
RJ Jose, A Manuel - The Lancet. Respiratory Medicine, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the globe. It is
associated with significant mortality, particularly in at-risk groups with poor prognostic …
associated with significant mortality, particularly in at-risk groups with poor prognostic …
COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation
W Miesbach, M Makris - Clinical and applied thrombosis …, 2020 - journals.sagepub.com
The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2
and is characterized by an exaggerated inflammatory response that can lead to severe …
and is characterized by an exaggerated inflammatory response that can lead to severe …
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in …
P Toniati, S Piva, M Cattalini, E Garrafa, F Regola… - Autoimmunity …, 2020 - Elsevier
A hyperinflammatory syndrome (HIS) may cause a life-threatening acute respiratory distress
syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 …
syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 …
Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels
I Léonard-Lorant, X Delabranche, F Séverac, J Helms… - Radiology, 2020 - pubs.rsna.org
Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to
d-Dimer Levels | Radiology RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu …
d-Dimer Levels | Radiology RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu …
Thrombosis risk associated with COVID-19 infection. A scoping review
F Al-Ani, S Chehade, A Lazo-Langner - Thrombosis research, 2020 - Elsevier
Background Infection by the 2019 novel coronavirus (COVID-19) has been reportedly
associated with a high risk of thrombotic complications. So far information is scarce and …
associated with a high risk of thrombotic complications. So far information is scarce and …
Diagnosis, prevention, and treatment of thromboembolic complications in COVID-19: report of the National Institute for Public Health of the Netherlands
A potential link between mortality, d-dimer values, and a prothrombotic syndrome has been
reported in patients with coronavirus disease 2019 (COVID-19) infection. The National …
reported in patients with coronavirus disease 2019 (COVID-19) infection. The National …
Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
DE Leisman, CS Deutschman, M Legrand - Intensive care medicine, 2020 - Springer
Current management guidelines for COVID-19 reflect the assumption that critically ill
patients infected with SARS-CoV-2 develop acute respiratory distress syndrome (ARDS) …
patients infected with SARS-CoV-2 develop acute respiratory distress syndrome (ARDS) …
Vascular skin symptoms in COVID‐19: a French observational study
JD Bouaziz, TA Duong, M Jachiet… - Journal of the …, 2020 - pmc.ncbi.nlm.nih.gov
Coronavirus 19 (COVID-19) was declared as a pandemic viral infection by the World Health
Organization on 11 March 2020. Usual clinical manifestations of COVID-19 infection include …
Organization on 11 March 2020. Usual clinical manifestations of COVID-19 infection include …